Atopic keratoconjunctivitis: A review.

J Am Acad Dermatol

Department of Ophthalmology, Baylor College of Medicine, Houston, Texas.

Published: March 2014

Atopic keratoconjunctivitis is a chronic noninfectious inflammatory condition and is one of the most severe ophthalmic complications associated with atopic dermatitis. It requires prompt and effective treatment to prevent permanent vision loss. Complications of atopic keratoconjunctivitis include cataracts, keratoconus, infectious keratitis, blepharitis, tear dysfunction, and steroid-induced glaucoma. All treatment for atopic keratoconjunctivitis should be managed in conjunction with an ophthalmologist, and immediate referral is indicated when there is moderate to severe irritation, increased redness, discharge, or any visual symptoms. Treatment options include a combination of mast cell inhibitors, antihistamines, corticosteroids, and calcineurin inhibitors.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2013.10.036DOI Listing

Publication Analysis

Top Keywords

atopic keratoconjunctivitis
16
atopic
5
keratoconjunctivitis review
4
review atopic
4
keratoconjunctivitis chronic
4
chronic noninfectious
4
noninfectious inflammatory
4
inflammatory condition
4
condition severe
4
severe ophthalmic
4

Similar Publications

Allergic conjunctivitis (AC) is characterized by inflammatory responses in the conjunctiva and is often complicated by atopic dermatitis and mechanical irritation. Vernal keratoconjunctivitis (VKC), a severe subtype of AC, presents unique challenges in its diagnosis and management, particularly in pediatric patients. This case report describes an eight-year-old girl with VKC who exhibited poor adherence to a prescribed regimen of 0.

View Article and Find Full Text PDF

[Efficacy of biologics for severe asthma on allergic comorbidities].

Rev Mal Respir

November 2024

Service de pneumologie et centre de référence des maladies pulmonaires rares, AP-HP Nord, hôpital Bichat, 75018 Paris, France; Inserm UMR1152, université Paris Cité, Paris, France.

Article Synopsis
  • Some treatments called biologics can help people with severe asthma and other allergic diseases like skin issues and food allergies.
  • Dupilumab has been shown to work well for skin problems and has been approved, while Omalizumab helps with allergies but isn't approved for that use yet.
  • There are promising ideas about combining biologic therapy with other treatments for allergies, but more research is needed to confirm if they really work.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze the link between inflammatory conditions in the eyes and body and the development of pterygium, a growth on the eye's surface.
  • Researchers used electronic medical records from Clalit Health Services in Israel, comparing over 94,000 pterygium patients with nearly 379,000 matched controls based on age, sex, and ethnicity.
  • Results showed significant associations between pterygium and several inflammatory conditions, both ocular (like vernal keratoconjunctivitis and blepharitis) and systemic (like asthma and atopic dermatitis), indicating these conditions may increase the risk of developing pterygium.
View Article and Find Full Text PDF

Purpose: Vernal keratoconjunctivitis (VKC) is a refractory ocular allergic disorder that mainly affects boys. Long-term follow-up has been rarely reported for VKC. We investigated the long-term clinical outcome of VKC to identify relevant clinical features of prognostic value based on follow-up for a median of 70 months.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!